Fig. 2

Summary of the observed experimental data and efficacy estimates against prevalence and parasite intensity. Prevalence (the percentage of infected individuals) and percentage parasite densities (the mean percentage of infected erythrocytes out of 1200 cells per host) in control (column 1) and treatment (column 2) mice for transmission cycles 1–4 (x-axis) and for biting rates 1–5 (1–5 mosquito bites per mouse, y-axis). Corresponding  % prevalence efficacy (top right) and % intensity efficacy (bottom right) estimated for each biting rate and transmission cycle using the probabilistic Bayesian model